May 20, 2021

Proceedings from the first in a series of 11 integrated webinars held in association with the 2021 ONS Annual Congress. Featuring perspectives from Drs Carey K Anders, Kathy D Miller and Sara M Tolaney on cases from the practices of Ms Gretchen Santos Fulgencio, Ms Allie Hershey and Ms Kelly Leonard, including the following topics:

• Introduction (0:00)
• Management of Estrogen Receptor (ER)-Positive Breast Cancer (9:58)
• Case: A woman in her early 30s with localized ER/progesterone receptor (PR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer and 3 positive nodes — Gretchen Santos Fulgencio, MSN, FNP-BC (10:31)
• Case: A woman in her early 50s with ER-positive, HER2-negative metastatic breast cancer and a PIK3CA tumor mutation — Kelly Leonard, MSN, FNP-BC (31:34)
• Treatment of HER2-Positive Breast Cancer (41:14)
• Case: A woman in her early 30s with localized ER/PR-positive, HER2-positive breast cancer and residual disease after neoadjuvant treatment — Ms Leonard (41:29)
• Case: A woman in her early 70s with metastatic HER2-positive breast cancer — Ms Fulgencio (53:16)
• Case: A woman in her mid-40s with ER/PR-positive, HER2-positive metastatic breast cancer — Allie Hershey, MSN, RN, ANP-BC, AOCNP (1:02:04)
• Case: A woman in her mid-60s with ER-positive, HER2-positive metastatic breast cancer and brain metastases — Ms Leonard (1:13:44)
• Care of Patients with Triple-Negative Breast Cancer (TNBC) (1:18:33)
• Case: A woman in her early 50s with metastatic BRCA wild-type TNBC, PD-L1-positive — Ms Hershey (1:19:14)

NCPD information and select publications